A detailed history of Caitong International Asset Management Co., LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 1,594 shares of ABBV stock, worth $293,327. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,594
Holding current value
$293,327
% of portfolio
0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$169.2 - $216.66 $269,704 - $345,356
1,594 New
1,594 $334 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.